Replacing Faulty Heart Devices Costs Medicare $1.5 Billion in 10 Years
On October 2nd, The New York Times
posted an article titled, “Replacing Faulty Heart Devices Costs Medicare $1.5
Billion in 10 Years.” In the article, it discusses how about 73,000 people on Medicare
had to have a heart device replaced because of recalls, failures, infections,
or necessary upgrades. These replaces have cost Medicare $1.5 billion but also
costs $140 million in out of pocket payments for patients. From 2003 to 2012
device recalls have nearly doubled, this is troubling for health officials. Not
only are the patients receiving faulty devices but hospitals have to go back
and collect detailed information identifying failed
devices, this is an extra step officials must
take in the care process.
While hospitals have no clue when they are
implementing these devices, many times they are blamed for the failure of the equipment.
When patients face complications they often go back to the hospital questioning
what’s wrong. Like the rest of the world we live in there are constantly new
technologies hoping to improve daily tasks but what is the cost? Technologies
are working to cut production costs as low as they can to increase profitability but when
the devices need to be replace it often costs more. This is where hospital officials
need to make the decision to stick with the older and more reliable technology
or to try the next best thing and hope for the best.
The New York Times Article
There's something to be said for not being on the cutting edge of technology. These devices go through a lot of testing before they get FDA approval, so there's a reasonable expectation that they are safe.
ReplyDeleteMany devices are not tested for 10 years for longevity, failure of the equipment, if we waited 10 years for a potential life saving device to be approved, more lives I believe would be lost than the ones we could have potentially saved. As stated by Dr. Bonica, the FDA goes through a lengthy process as do companies in their research and development to get devices approved. The intent of these companies is not to harm, but to save lives. Additionally, many implantable devices usually have a longevity/life time given to the patients, I.E. a heart valve replacement usually has a life time of 10 years; if it is covered the first time, does that mean the insurance has/should cover it a second time? This is an ethical conversation that we could have, it comes down to pre-existing conditions and we are not sure where the future in healthcare policy is taking us, but this can lead to many great discussions.
ReplyDelete